ATF2 - at the crossroad of nuclear and cytosolic functions

Journal of Cell Science

Volumn 125, Issue 12, 2012, Pages 2815-2824

  Lau, Eric ^a   Ronai, Ze'ev A ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

ATF2; DNA damage; JNK; Melanoma; Mitochondria; P38 MAPK; PKC; Skin cancer; Transcription

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ISOENZYME; PROTEIN KINASE C; TRANSCRIPTION FACTOR;

CELL DEATH; CELL FUNCTION; CELL MATURATION; CELL NUCLEUS; CELL PROLIFERATION; CELL STRESS; CELLULAR DISTRIBUTION; CYTOPLASM; CYTOSOL; DNA DAMAGE; DROSOPHILA; EDITORIAL; GENE CONTROL; GENE FUNCTION; GENE LOCATION; GENETIC TRANSCRIPTION; GENOTOXICITY; HUMAN; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; YEAST;

ACTIVATING TRANSCRIPTION FACTOR 2; AMINO ACID MOTIFS; ANIMALS; CELL NUCLEUS; CYTOSOL; DNA DAMAGE; HUMANS; PHOSPHORYLATION; PROTEIN KINASE C-EPSILON; PROTEIN TRANSPORT; SKIN NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 84867904006     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.095000     Document Type: Editorial

References (125)

1. Abdel-Hafiz, H. A., Chen, C. Y., Marcell, T., Kroll, D. J. and Hoeffler, J. P. (1993). Structural determinants outside of the leucine zipper influence the interactions of CREB and ATF-2: interaction of CREB with ATF-2 blocks E1a-ATF-2 complex formation. Oncogene 8, 1161-1174.
2. Abu-Hamad, S., Zaid, H., Israelson, A., Nahon, E. and Shoshan-Barmatz, V. (2008). Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: mapping the site of binding. J. Biol. Chem. 283, 13482-13490.
3. Ackermann, J., Ashton, G., Lyons, S., James, D., Hornung, J. P., Jones, N. and Breitwieser, W. (2011). Loss of ATF2 function leads to cranial motoneuron degeneration during embryonic mouse development. PLoS ONE 6, e19090
4. Agelopoulos, M. and Thanos, D. (2006). Epigenetic determination of a cell-specific gene expression program by ATF-2 and the histone variant macroH2A. EMBO J. 25, 4843-4853.
5. Ahn, J., Choi, J. H., Won, M., Kang, C. M., Gyun, M. R., Park, H. M., Kim, C. H. and Chung, K. S. (2011). The activation of p38 MAPK primarily contributes to UVinduced RhoB expression by recruiting the c-Jun and p300 to the distal CCAAT box of the RhoB promoter. Biochem. Biophys. Res. Commun. 409, 211-216.
6. Akimoto, T., Pohnert, S. C., Li, P., Zhang, M., Gumbs, C., Rosenberg, P. B., Williams, R. S. and Yan, Z. (2005). Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway. J. Biol. Chem. 280, 19587-19593.
7. Al-Salleeh, F. and Petro, T. M. (2008). Promoter analysis reveals critical roles for SMAD-3 and ATF-2 in expression of IL-23 p19 in macrophages. J. Immunol. 181, 4523-4533.
8. Altmayr, F., Jusek, G. and Holzmann, B. (2010). The neuropeptide calcitonin generelated peptide causes repression of tumor necrosis factor-alpha transcription and suppression of ATF-2 promoter recruitment in Toll-like receptor-stimulated dendritic cells. J. Biol. Chem. 285, 3525-3531.
9. Arora, H., Qureshi, R., Park, A. K. and Park, W. Y. (2011). Coordinated regulation of ATF2 by miR-26b in c-irradiated lung cancer cells. PLoS ONE 6, e23802.
10. Averous, J., Bruhat, A., Jousse, C., Carraro, V., Thiel, G. and Fafournoux, P. (2004). Induction of CHOP expression by amino acid limitation requires both ATF4 expression and ATF2 phosphorylation. J. Biol. Chem. 279, 5288-5297.
11. Bailey, J. and Europe-Finner, G. N. (2005). Identification of human myometrial target genes of the c-Jun NH2-terminal kinase (JNK) pathway: the role of activating transcription factor 2 (ATF2) and a novel spliced isoform ATF2-small. J. Mol. Endocrinol. 34, 19-35.
12. Bailey, J., Phillips, R. J., Pollard, A. J., Gilmore, K., Robson, S. C. and Europe-Finner, G. N. (2002). Characterization and functional analysis of cAMP response element modulator protein and activating transcription factor 2 (ATF2) isoforms in the human myometrium during pregnancy and labor: identification of a novel ATF2 species with potent transactivation properties. J. Clin. Endocrinol. Metab. 87, 1717-1728.
13. Beier, F., Lee, R. J., Taylor, A. C., Pestell, R. G. and LuValle, P. (1999). Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes. Proc. Natl. Acad. Sci. USA 96, 1433-1438.
14. Beier, F., Ali, Z., Mok, D., Taylor, A. C., Leask, T., Albanese, C., Pestell, R. G. and LuValle, P. (2001). TGFbeta and PTHrP control chondrocyte proliferation by activating cyclin D1 expression. Mol. Biol. Cell 12, 3852-3863.
15. Berger, A. J., Kluger, H. M., Li, N., Kielhorn, E., Halaban, R., Ronai, Z. and Rimm, D. L. (2003). Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival. Cancer Res. 63, 8103-8107.
16. Bhoumik, A., Jones, N. and Ronai, Z. (2004). Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity. Proc. Natl. Acad. Sci. USA 101, 4222-4227.
17. Bhoumik, A., Takahashi, S., Breitweiser, W., Shiloh, Y., Jones, N. and Ronai, Z. (2005). ATM-dependent phosphorylation of ATF2 is required for the DNA damage response. Mol. Cell 18, 577-587.
18. Bhoumik, A., Lopez-Bergami, P. and Ronai, Z. (2007). ATF2 on the double - activating transcription factor and DNA damage response protein. Pigment Cell Res. 20, 498-506.
19. Bhoumik, A., Fichtman, B., Derossi, C., Breitwieser, W., Kluger, H. M., Davis, S., Subtil, A., Meltzer, P., Krajewski, S., Jones, N. et al. (2008a). Suppressor role of activating transcription factor 2 (ATF2) in skin cancer. Proc. Natl. Acad. Sci. USA 105, 1674-1679.
20. Bhoumik, A., Singha, N., O'Connell, M. J. and Ronai, Z. A. (2008b). Regulation of TIP60 by ATF2 modulates ATM activation. J. Biol. Chem. 283, 17605-17614.
21. Breitwieser, W., Lyons, S., Flenniken, A. M., Ashton, G., Bruder, G., Willington, M., Lacaud, G., Kouskoff, V. and Jones, N. (2007). Feedback regulation of p38 activity via ATF2 is essential for survival of embryonic liver cells. Genes Dev. 21, 2069-2082.
22. Bruhat, A., Chérasse, Y., Maurin, A. C., Breitwieser, W., Parry, L., Deval, C., Jones, N., Jousse, C. and Fafournoux, P. (2007). ATF2 is required for amino acidregulated transcription by orchestrating specific histone acetylation. Nucleic Acids Res. 35, 1312-1321.
23. Cam, H., Balciunaite, E., Blais, A., Spektor, A., Scarpulla, R. C., Young, R., Kluger, Y. and Dynlacht, B. D. (2004). A common set of gene regulatory networks links metabolism and growth inhibition. Mol. Cell 16, 399-411.
24. Chaveroux, C., Jousse, C., Cherasse, Y., Maurin, A. C., Parry, L., Carraro, V., Derijard, B., Bruhat, A. and Fafournoux, P. (2009). Identification of a novel amino acid response pathway triggering ATF2 phosphorylation in mammals. Mol. Cell. Biol. 29, 6515-6526.
25. Chen, S. Y., Takeuchi, S., Urabe, K., Hayashida, S., Kido, M., Tomoeda, H., Uchi, H., Dainichi, T., Takahara, M., Shibata, S. et al. (2008). Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous angiosarcoma and pyogenic granuloma. J. Cutan. Pathol. 35, 722-730.
26. Cho, S. G., Bhoumik, A., Broday, L., Ivanov, V., Rosenstein, B. and Ronai, Z. (2001). TIP49b, a regulator of activating transcription factor 2 response to stress and DNA damage. Mol. Cell. Biol. 21, 8398-8413.
27. Choi, J. H., Cho, H. K., Choi, Y. H. and Cheong, J. (2009). Activating transcription factor 2 increases transactivation and protein stability of hypoxia-inducible factor 1alpha in hepatocytes. Biochem. J. 424, 285-296.
28. Cirillo, G., Casalino, L., Vallone, D., Caracciolo, A., De Cesare, D. and Verde, P. (1999). Role of distinct mitogen-activated protein kinase pathways and cooperation between Ets-2, ATF-2, and Jun family members in human urokinase-type plasminogen activator gene induction by interleukin-1 and tetradecanoyl phorbol acetate. Mol. Cell. Biol. 19, 6240-6252.
29. Dam, H., Wilhelm, D., Herr, I., Steffen, A., Herrlich, P. and Angel, P. (1995). ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J. 14, 1798-811.
30. D'Orazio, D., Besser, D., Marksitzer, R., Kunz, C., Hume, D. A., Kiefer, B. and Nagamine, Y. (1997). Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2. Gene 201, 179-187.
31. Deng, X., Liu, H., Huang, J., Cheng, L., Keller, E. T., Parsons, S. J. and Hu, C. D. (2008). Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression. Cancer Res. 68, 9663-9670.
32. Deng, X., Elzey, B. D., Poulson, J. M., Morrison, W. B., Ko, S. C., Hahn, N. M., Ratliff, T. L. and Hu, C. D. (2011). Ionizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patients. Am. J. Cancer Res. 1, 834-844.
33. Desch, M., Hackmayer, G. and Todorov, V. T. (2011). Identification of ATF2 as a transcriptional regulator of renin gene. Biol. Chem. 393, 93-100.
34. Diring, J., Camuzeaux, B., Donzeau, M., Vigneron, M., Rosa-Calatrava, M., Kedinger, C. and Chatton, B. (2011). A cytoplasmic negative regulator isoform of ATF7 impairs ATF7 and ATF2 phosphorylation and transcriptional activity. PLoS ONE 6, e23351.
35. Dutton-Regester, K. and Hayward, N. K. (2012). Reviewing the somatic genetics of melanoma: from current to future analytical approaches. Pigment Cell Melanoma Res. 25, 144-154.
36. Duyndam, M. C., van Dam, H., Smits, P. H., Verlaan, M., van der Eb, A. J. and Zantema, A. (1999). The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A. Oncogene 18, 2311-2321.
37. Falvo, J. V., Thanos, D. and Maniatis, T. (1995). Reversal of intrinsic DNA bends in the IFN beta gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell 83, 1101-1111.
38. Falvo, J. V., Parekh, B. S., Lin, C. H., Fraenkel, E. and Maniatis, T. (2000). Assembly of a functional beta interferon enhanceosome is dependent on ATF-2-c-jun heterodimer orientation. Mol. Cell. Biol. 20, 4814-4825.
39. Firestein, R. and Feuerstein, N. (1998). Association of activating transcription factor 2 (ATF2) with the ubiquitin-conjugating enzyme hUBC9. Implication of the ubiquitin/proteasome pathway in regulation of ATF2 in T cells. J. Biol. Chem. 273, 5892-5902.
40. Franchimont, N., Durant, D., Rydziel, S. and Canalis, E. (1999). Platelet-derived growth factor induces interleukin-6 transcription in osteoblasts through the activator protein-1 complex and activating transcription factor-2. J. Biol. Chem. 274, 6783-6789.
41. Fritz, G. and Kaina, B. (2001). Transcriptional activation of the small GTPase gene rhoB by genotoxic stress is regulated via a CCAAT element. Nucleic Acids Res. 29, 792-798.
42. Fu, L., Balasubramanian, M., Shan, J., Dudenhausen, E. E. and Kilberg, M. S. (2011). Auto-activation of c-JUN gene by amino acid deprivation of hepatocellular carcinoma cells reveals a novel c-JUN-mediated signaling pathway. J. Biol. Chem. 286, 36724-36738.
43. Fuchs, S. Y. and Ronai, Z. (1999). Ubiquitination and degradation of ATF2 are dimerization dependent. Mol. Cell. Biol. 19, 3289-3298.
44. Fuchs, S. Y., Xie, B., Adler, V., Fried, V. A., Davis, R. J. and Ronai, Z. (1997). c-Jun NH2-terminal kinases target the ubiquitination of their associated transcription factors. J. Biol. Chem. 272, 32163-32168.
45. Georgopoulos, K., Morgan, B. A. and Moore, D. D. (1992). Functionally distinct isoforms of the CRE-BP DNA-binding protein mediate activity of a T-cell-specific enhancer. Mol. Cell. Biol. 12, 747-757.
46. Gong, P., Stewart, D., Hu, B., Vinson, C. and Alam, J. (2002). Multiple basic-leucine zipper proteins regulate induction of the mouse heme oxygenase-1 gene by arsenite. Arch. Biochem. Biophys. 405, 265-274.
47. Gueorguiev, V. D., Cheng, S. Y. and Sabban, E. L. (2006). Prolonged activation of cAMP-response element-binding protein and ATF-2 needed for nicotine-triggered elevation of tyrosine hydroxylase gene transcription in PC12 cells. J. Biol. Chem. 281, 10188-10195.
48. Gupta, S., Campbell, D., Dérijard, B. and Davis, R. J. (1995). Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267, 389-393.
49. Hagmeyer, B. M., Angel, P. and van Dam, H. (1995). Modulation of AP-1/ATF transcription factor activity by the adenovirus-E1A oncogene products. Bioessays 17, 621-629.
50. Hai, T. W., Liu, F., Coukos, W. J. and Green, M. R. (1989). Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev. 3, 2083-2090.
51. Han, S. I., Yasuda, K. and Kataoka, K. (2011). ATF2 interacts with beta-cell-enriched transcription factors, MafA, Pdx1, and beta2, and activates insulin gene transcription. J. Biol. Chem. 286, 10449-10456.
52. Hay, C. W., Ferguson, L. A. and Docherty, K. (2007). ATF-2 stimulates the human insulin promoter through the conserved CRE2 sequence. Biochim. Biophys. Acta 1769, 79-91.
53. Hilberg, F., Aguzzi, A., Howells, N. and Wagner, E. F. (1993). c-jun is essential for normal mouse development and hepatogenesis. Nature 365, 179-181.
54. Hirose, N., Maekawa, T., Shinagawa, T. and Ishii, S. (2009). ATF-2 regulates lipopolysaccharide-induced transcription in macrophage cells. Biochem. Biophys. Res. Commun. 385, 72-77.
55. Hondares, E., Iglesias, R., Giralt, A., Gonzalez, F. J., Giralt, M., Mampel, T. and Villarroya, F. (2011). Thermogenic activation induces FGF21 expression and release in brown adipose tissue. J. Biol. Chem. 286, 12983-12990.
56. Jia, S., Noma, K. and Grewal, S. I. (2004). RNAi-independent heterochromatin nucleation by the stress-activated ATF/CREB family proteins. Science 304, 1971-1976.
57. Jin, C., Li, H., Murata, T., Sun, K., Horikoshi, M., Chiu, R. and Yokoyama, K. K. (2002). JDP2, a repressor of AP-1, recruits a histone deacetylase 3 complex to inhibit the retinoic acid-induced differentiation of F9 cells. Mol. Cell. Biol. 22, 4815-4826.
58. Johnson, R. S., van Lingen, B., Papaioannou, V. E. and Spiegelman, B. M. (1993). A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev. 7, 1309-1317.
59. Kara, C. J., Liou, H. C., Ivashkiv, L. B. and Glimcher, L. H. (1990). A cDNA for a human cyclic AMP response element-binding protein which is distinct from CREB and expressed preferentially in brain. Mol. Cell. Biol. 10, 1347-1357.
60. Karanam, B., Wang, L., Wang, D., Liu, X., Marmorstein, R., Cotter, R. and Cole, P. A. (2007). Multiple roles for acetylation in the interaction of p300 HAT with ATF-2. Biochemistry 46, 8207-8216.
61. Kawasaki, H., Song, J., Eckner, R., Ugai, H., Chiu, R., Taira, K., Shi, Y., Jones, N. and Yokoyama, K. K. (1998). p300 and ATF-2 are components of the DRF complex, which regulates retinoic acid- and E1A-mediated transcription of the c-jun gene in F9 cells. Genes Dev. 12, 233-245.
62. Kim, H. S., Choi, E. S., Shin, J. A., Jang, Y. K. and Park, S. D. (2004). Regulation of Swi6/HP1-dependent heterochromatin assembly by cooperation of components of the mitogen-activated protein kinase pathway and a histone deacetylase Clr6. J. Biol. Chem. 279, 42850-42859.
63. Kim, S. J., Wagner, S., Liu, F., O'Reilly, M. A., Robbins, P. D. and Green, M. R. (1992). Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature 358, 331-334.
64. Koch, U. and Radtke, F. (2007). Notch and cancer: a double-edged sword. Cell. Mol. Life Sci. 64, 2746-2762.
65. Kodeboyina, S., Balamurugan, P., Liu, L. and Pace, B. S. (2010). cJun modulates Ggamma-globin gene expression via an upstream cAMP response element. Blood Cells Mol. Dis. 44, 7-15.
66. Kool, J., Hamdi, M., Cornelissen-Steijger, P., van der Eb, A. J., Terleth, C. and van Dam, H. (2003). Induction of ATF3 by ionizing radiation is mediated via a signaling pathway that includes ATM, Nibrin1, stress-induced MAPkinases and ATF-2. Oncogene 22, 4235-4242.
67. Kravets, A., Hu, Z., Miralem, T., Torno, M. D. and Maines, M. D. (2004). Biliverdin reductase, a novel regulator for induction of activating transcription factor-2 and heme oxygenase-1. J. Biol. Chem. 279, 19916-19923.
68. Kristiansen, M., Hughes, R., Patel, P., Jacques, T. S., Clark, A. R. and Ham, J. (2010). Mkp1 is a c-Jun target gene that antagonizes JNK-dependent apoptosis in sympathetic neurons. J. Neurosci. 30, 10820-10832.
69. Kumawat, K., Pathak, S. K., Spetz, A. L., Kundu, M. and Basu, J. (2010). Exogenous Nef is an inhibitor of Mycobacterium tuberculosis-induced tumor necrosis factoralpha production and macrophage apoptosis. J. Biol. Chem. 285, 12629-12637.
70. Larsson, L. G. and Henriksson, M. A. (2010). The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy. Exp. Cell Res. 316, 1429-1437.
71. Lau, E., Kluger, H., Varsano, T., Lee, K., Scheffler, I., Rimm, D. L., Ideker, T. and Ronai, Z. A. (2012). PKCe promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria. Cell 148, 543-555.
72. Lawrence, M. C., Naziruddin, B., Levy, M. F., Jackson, A. and McGlynn, K. (2011). Calcineurin/nuclear factor of activated T cells and MAPK signaling induce TNFalpha gene expression in pancreatic islet endocrine cells. J. Biol. Chem. 286, 1025-1036.
73. Lee, S. H., Bahn, J. H., Whitlock, N. C. and Baek, S. J. (2010). Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways. Oncogene 29, 5182-5192.
74. Li, S., Ezhevsky, S., Dewing, A., Cato, M. H., Scortegagna, M., Bhoumik, A., Breitwieser, W., Braddock, D., Eroshkin, A., Qi, J. et al. (2010). Radiation sensitivity and tumor susceptibility in ATM phospho-mutant ATF2 mice. Genes Cancer 1, 316-330.
75. Li, X. Y. and Green, M. R. (1996). Intramolecular inhibition of activating transcription factor-2 function by its DNA-binding domain. Genes Dev. 10, 517-527.
76. Liao, H., Hyman, M. C., Baek, A. E., Fukase, K. and Pinsky, D. J. (2010). cAMP/CREB-mediated transcriptional regulation of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) expression. J. Biol. Chem. 285, 14791-14805.
77. Licht, A. H., Pein, O. T., Florin, L., Hartenstein, B., Reuter, H., Arnold, B., Lichter, P., Angel, P. and Schorpp-Kistner, M. (2006). JunB is required for endothelial cell morphogenesis by regulating core-binding factor beta. J. Cell Biol. 175, 981-991.
78. Lin, D. W., Chang, I. C., Tseng, A., Wu, M. L., Chen, C. H., Patenaude, C. A., Layne, M. D. and Yet, S. F. (2008). Transforming growth factor beta up-regulates cysteine-rich protein 2 in vascular smooth muscle cells via activating transcription factor 2. J. Biol. Chem. 283, 15003-15014.
79. Liu, H., Deng, X., Shyu, Y. J., Li, J. J., Taparowsky, E. J. and Hu, C. D. (2006). Mutual regulation of c-Jun and ATF2 by transcriptional activation and subcellular localization. EMBO J. 25, 1058-1069.
80. Liu, W., Ouyang, X., Yang, J., Liu, J., Li, Q., Gu, Y., Fukata, M., Lin, T., He, J. C., Abreu, M. et al. (2009). AP-1 activated by toll-like receptors regulates expression of IL-23 p19. J. Biol. Chem. 284, 24006-24016.
81. Livingstone, C., Patel, G. and Jones, N. (1995). ATF-2 contains a phosphorylationdependent transcriptional activation domain. EMBO J. 14, 1785-1797.
82. Lopez-Bergami, P., Lau, E. and Ronai, Z. (2010). Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nat. Rev. Cancer 10, 65-76.
83. Ma, C., Ying, C., Yuan, Z., Song, B., Li, D., Liu, Y., Lai, B., Li, W., Chen, R., Ching, Y. P. et al. (2007). dp5/HRK is a c-Jun target gene and required for apoptosis induced by potassium deprivation in cerebellar granule neurons. J. Biol. Chem. 282, 30901-30909.
84. Maekawa, T., Bernier, F., Sato, M., Nomura, S., Singh, M., Inoue, Y., Tokunaga, T., Imai, H., Yokoyama, M., Reimold, A. et al. (1999). Mouse ATF-2 null mutants display features of a severe type of meconium aspiration syndrome. J. Biol. Chem. 274, 17813-17819.
85. Maekawa, T., Shinagawa, T., Sano, Y., Sakuma, T., Nomura, S., Nagasaki,K., Miki, Y., Saito-Ohara, F., Inazawa, J., Kohno, T. et al. (2007). Reduced levels of ATF-2 predispose mice to mammary tumors. Mol. Cell. Biol. 27, 1730-1744.
86. Maekawa, T., Sano, Y., Shinagawa, T., Rahman, Z., Sakuma, T., Nomura, S., Licht, J. D. and Ishii, S. (2008). ATF-2 controls transcription of Maspin and GADD45 alpha genes independently from p53 to suppress mammary tumors. Oncogene 27, 1045-1054.
87. Markovics, J. A., Araya, J., Cambier, S., Somanath, S., Gline, S., Jablons, D., Hill, A., Wolters, P. J. and Nishimura, S. L. (2011). Interleukin-1beta induces increased transcriptional activation of the transforming growth factor-beta-activating integrin subunit beta8 through altering chromatin architecture. J. Biol. Chem. 286, 36864-36874.
88. Martin-Villalba, A., Winter, C., Brecht, S., Buschmann, T., Zimmermann, M. and Herdegen, T. (1998). Rapid and long-lasting suppression of the ATF-2 transcription factor is a common response to neuronal injury. Brain Res. Mol. Brain Res. 62, 158-166.
89. Matsuo, N., Tanaka, S., Gordon, M. K., Koch, M., Yoshioka, H. and Ramirez, F. (2006). CREB-AP1 protein complexes regulate transcription of the collagen XXIV gene (Col24a1) in osteoblasts. J. Biol. Chem. 281, 5445-5452.
90. Mayer, S. I., Dexheimer, V., Nishida, E., Kitajima, S. and Thiel, G. (2008). Expression of the transcriptional repressor ATF3 in gonadotrophs is regulated by Egr-1, CREB, and ATF2 after gonadotropin-releasing hormone receptor stimulation. Endocrinology 149, 6311-6325.
91. Merika, M., Williams, A. J., Chen, G., Collins, T. and Thanos, D. (1998). Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. Mol. Cell 1, 277-287.
92. Min, B. W., Kim, C. G., Ko, J., Lim, Y., Lee, Y. H. and Shin, S. Y. (2008). Transcription of the protein kinase C-delta gene is activated by JNK through c-Jun and ATF2 in response to the anticancer agent doxorubicin. Exp. Mol. Med. 40, 699-708.
93. Nagadoi, A., Nakazawa, K., Uda, H., Okuno, K., Maekawa, T., Ishii, S. and Nishimura, Y. (1999). Solution structure of the transactivation domain of ATF-2 comprising a zinc finger-like subdomain and a flexible subdomain. J. Mol. Biol. 287, 593-607.
94. Nagase, T., Sudo, T., Maekawa, T., Yoshimura, T., Fujisawa, J., Yoshida, M. and Ishii, S. (1990). Promoter region of the human CRE-BP1 gene encoding the transcriptional regulator binding to the cyclic AMP response element. J. Biol. Chem. 265, 17300-17306.
95. Nogueira, E. F. and Rainey, W. E. (2010). Regulation of aldosterone synthase by activator transcription factor/cAMP response element-binding protein family members. Endocrinology 151, 1060-1070.
96. O'Neil, J. D., Owen, T. J., Wood, V. H., Date, K. L., Valentine, R., Chukwuma, M. B., Arrand, J. R., Dawson, C. W. and Young, L. S. (2008). Epstein-Barr virusencoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. J. Gen. Virol. 89, 2833-2842.
97. Ouwens, D. M., de Ruiter, N. D., van der Zon, G. C., Carter, A. P., Schouten, J., van der Burgt, C., Kooistra, K., Bos, J. L., Maassen, J. A. and van Dam, H. (2002). Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38. EMBO J. 21, 3782-3793.
98. Pearson, A. G., Curtis, M. A., Waldvogel, H. J., Faull, R. L. and Dragunow, M. (2005). Activating transcription factor 2 expression in the adult human brain: association with both neurodegeneration and neurogenesis. Neuroscience 133, 437-451.
99. Penix, L. A., Sweetser, M. T., Weaver, W. M., Hoeffler, J. P., Kerppola, T. K. and Wilson, C. B. (1996). The proximal regulatory element of the interferon-gamma promoter mediates selective expression in T cells. J. Biol. Chem. 271, 31964-31972.
100. Read, M. A., Whitley, M. Z., Gupta, S., Pierce, J. W., Best, J., Davis, R. J. and Collins, T. (1997). Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogenactivated protein kinase pathways. J. Biol. Chem. 272, 2753-2761.
101. Reimold, A. M., Grusby, M. J., Kosaras, B., Fries, J. W., Mori, R., Maniwa, S., Clauss, I. M., Collins, T., Sidman, R. L., Glimcher, M. J. et al. (1996). Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice. Nature 379, 262-265.
102. Ronai, Z., Yang, Y. M., Fuchs, S. Y., Adler, V., Sardana, M. and Herlyn, M. (1998). ATF2 confers radiation resistance to human melanoma cells. Oncogene 16, 523-531.
103. Salameh, A., Galvagni, F., Anselmi, F., De Clemente, C., Orlandini, M. and Oliviero, S. (2010). Growth factor stimulation induces cell survival by c-Jun. ATF2-dependent activation of Bcl-XL. J. Biol. Chem. 285, 23096-23104.
104. Sanalkumar, R., Indulekha, C. L., Divya, T. S., Divya, M. S., Anto, R. J., Vinod, B., Vidyanand, S., Jagatha, B., Venugopal, S. and James, J. (2010). ATF2 maintains a subset of neural progenitors through CBF1/Notch independent Hes-1 expression and synergistically activates the expression of Hes-1 in Notch-dependent neural progenitors. J. Neurochem. 113, 807-818.
105. Seong, K. H., Li, D., Shimizu, H., Nakamura, R. and Ishii, S. (2011). Inheritance of stress-induced, ATF-2-dependent epigenetic change. Cell 145, 1049-1061.
106. Sevilla, A., Santos, C. R., Vega, F. M. and Lazo, P. A. (2004). Human vaccinia-related kinase 1 (VRK1) activates the ATF2 transcriptional activity by novel phosphorylation on Thr-73 and Ser-62 and cooperates with JNK. J. Biol. Chem. 279, 27458-27465.
107. Shah, M., Bhoumik, A., Goel, V., Dewing, A., Breitwieser, W., Kluger, H., Krajewski, S., Krajewska, M., Dehart, J., Lau, E. et al. (2010). A role for ATF2 in regulating MITF and melanoma development. PLoS Genet. 6, e1001258.
108. Shimizu, M., Nomura, Y., Suzuki, H., Ichikawa, E., Takeuchi, A., Suzuki, M., Nakamura, T., Nakajima, T. and Oda, K. (1998). Activation of the rat cyclin A promoter by ATF2 and Jun family members and its suppression by ATF4. Exp. Cell Res. 239, 93-103.
109. Shoshan-Barmatz, V., Zakar, M., Rosenthal, K. and Abu-Hamad, S. (2009). Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase. Biochim. Biophys. Acta 1787, 421-430.
110. Shuman, J. D., Cheong, J. and Coligan, J. E. (1997). ATF-2 and C/EBPalpha can form a heterodimeric DNA binding complex in vitro. Functional implications for transcriptional regulation. J. Biol. Chem. 272, 12793-12800.
111. Song, N., Kim, S. J., Kwon, H. Y., Son, S. W., Kim, K. S., Ahn, H. B. and Lee, Y. C. (2011). Transcriptional activation of human GM3 synthase (hST3Gal V) gene by valproic acid in ARPE-19 human retinal pigment epithelial cells. BMB Rep. 44, 405-409.
112. Suzuki, T., Yamakuni, T., Hagiwara, M. and Ichinose, H. (2002). Identification of ATF-2 as a transcriptional regulator for the tyrosine hydroxylase gene. J. Biol. Chem. 277, 40768-40774.
113. Takeda, J., Maekawa, T., Sudo, T., Seino, Y., Imura, H., Saito, N., Tanaka, C. and Ishii, S. (1991). Expression of the CRE-BP1 transcriptional regulator binding to the cyclic AMP response element in central nervous system, regenerating liver, and human tumors. Oncogene 6, 1009-1014.
114. Towers, E., Gilley, J., Randall, R., Hughes, R., Kristiansen, M. and Ham, J. (2009). The proapoptotic dp5 gene is a direct target of the MLK-JNK-c-Jun pathway in sympathetic neurons. Nucleic Acids Res. 37, 3044-3060.
115. Vale-Cruz, D. S., Ma, Q., Syme, J. and LuValle, P. A. (2008). Activating transcription factor-2 affects skeletal growth by modulating pRb gene expression. Mech. Dev. 125, 843-856.
116. van Dam, H. and Castellazzi, M. (2001). Distinct roles of Jun: Fos and Jun: ATF dimers in oncogenesis. Oncogene 20, 2453-2464.
117. Walia, V., Mu, E. W., Lin, J. C. and Samuels, Y. (2012). Delving into somatic variation in sporadic melanoma. Pigment Cell Melanoma Res. 25, 155-170.
118. Wang, L., Payton, R., Dai, W. and Lu, L. (2011). Hyperosmotic stress-induced ATF-2 activation through Polo-like kinase 3 in human corneal epithelial cells. J. Biol. Chem. 286, 1951-1958.
119. Xiao, L., Rao, J. N., Zou, T., Liu, L., Marasa, B. S., Chen, J., Turner, D. J., Zhou, H., Gorospe, M. and Wang, J. Y. (2007). Polyamines regulate the stability of activating transcription factor-2 mRNA through RNA-binding protein HuR in intestinal epithelial cells. Mol. Biol. Cell 18, 4579-4590.
120. Xiao, L., Rao, J. N., Zou, T., Liu, L., Yu, T. X., Zhu, X. Y., Donahue, J. M. and Wang, J. Y. (2010). Induced ATF-2 represses CDK4 transcription through dimerization with JunD inhibiting intestinal epithelial cell growth after polyamine depletion. Am. J. Physiol. Cell Physiol. 298, C1226-C1234.
121. Yamada, T., Yoshiyama, Y. and Kawaguchi, N. (1997). Expression of activating transcription factor-2 (ATF-2), one of the cyclic AMP response element (CRE) binding proteins, in Alzheimer disease and non-neurological brain tissues. Brain Res. 749, 329-334.
122. Yamasaki, T., Takahashi, A., Pan, J., Yamaguchi, N. and Yokoyama, K. K. (2009). Phosphorylation of Activation Transcription Factor-2 at Serine 121 by Protein Kinase C Controls c-Jun-mediated Activation of Transcription. J. Biol. Chem. 284, 8567-8581.
123. Villarreal, X. C. and Richter, J. D. (1995). Analysis of ATF2 gene expression during early Xenopus laevis development. Gene 153, 225-229.
124. Zhang, J. Y., Jiang, H., Gao, W., Wu, J., Peng, K., Shi, Y. F. and Zhang, X. J. (2008). The JNK/AP1/ATF2 pathway is involved in H2O2-induced acetylcholinesterase expression during apoptosis. Cell. Mol. Life Sci. 65, 1435-1445.
125. Zhu, W., Chandrasekharan, U. M., Bandyopadhyay, S., Morris, S. M., Jr, DiCorleto, P. E. and Kashyap, V. S. (2010). Thrombin induces endothelial arginase through AP-1 activation. Am. J. Physiol. Cell Physiol. 298, C952-C960.